VoxCell BioInnovation

Victoria, Canada · Founded 2020 · Privately Held (backing)

Developer of 3D (three-dimensional) bioprinted human tissue models designed to enhance drug development and testing accuracy. VoxCell BioInnovation is based in Victoria, Canada and was founded in 2020. It has raised $12.3 million across 2 recorded rounds; the latest was a $1.7 million seed round in Feb 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$12.3M
Last round
Seed Round
Feb 2025
No prints on record

No secondary trades in VoxCell BioInnovation shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of VoxCell BioInnovation with a free account
  • ·The complete investor list: 24 names
  • ·Watch VoxCell BioInnovation: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where VoxCell BioInnovation prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of VoxCell BioInnovation stock.